Paris - Delayed Quote EUR
Implanet S.A. (ALIMP.PA)
0.0972
-0.0028
(-2.80%)
At close: May 30 at 2:51:10 PM GMT+2
Key Executives
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ludovic Lastennet | CEO, Commercial Director & Director | 294k | -- | -- |
| Mr. David Dieumegard | Vice President of Financial | -- | -- | -- |
| Ms. Yvanna Peigne | Operations Manager | -- | -- | -- |
| Mr. Benjamin Letienne | VP of Marketing & International Sales and Director | -- | -- | -- |
Implanet S.A.
Technopole Bordeaux Montesquieu
AllEe FranCois Magendie
Martillac, 33650
France
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 46
Description
Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martillac, France.
Corporate Governance
Implanet S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available